William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Holley Announces Upsizing and Pricing of a Secondary Offering by Selling Stockholder
-
Clearwater Analytics to Participate in Upcoming Investor Conferences
-
Box, Inc. (BOX) Management Meetings Highlight Virtual Whiteboarding - William Blair
-
Rollins (ROL) Resolves SEC Investigation into Accounting Policies, Removing an Overhang - William Blair
-
William Blair Downgrades DENTSPLY SIRONA (XRAY) to Market Perform
-
Vertex Announces First Quarter 2022 Earnings Release and Conference Call Date; Presenting at Upcoming Investor Conferences
-
Vertex Announces First Quarter 2022 Earnings Release and Conference Call Date; Presenting at Upcoming Investor Conferences
-
William Blair Starts Sierra Wireless (SWIR) at Outperform
-
Versapay Acquires Leading Cash Application Fintech Company DadeSystems
-
CL ENTERPRISES WELCOMES NEW EXECUTIVES IN RESPONSE TO STRONG GROWTH
-
Vida Health Founder and CEO Stephanie Tilenius to Participate at William Blair Healthcare Innovators Conference
-
TiG Data Intelligence Unveils New Strategy That Places Cybersecurity at the Heart of Customer Digital Transformation Programmes; Rebrands as Kocho
-
Thomas H. Lee Partners Announces Growth Investment in Carpe Data
-
CCC Intelligent Solutions Holdings Inc. (CCCS) Prices 20M Share Offering at $9.70/sh
-
CCC Intelligent Solutions Holdings Inc. Announces Pricing of Secondary Offering of Common Stock by Selling Stockholders
-
IntelyCare Secures $115 Million Series C Financing Led by Janus Henderson Investors
-
RLJ exits Pro-Vac
-
"Current Valuation is Disconnected From Future Growth Outlook" - William Blair Reiterates Collegium Pharmaceutical (COLL) at Outperform
-
Specific Diagnostics Invited to Present at the William Blair & Company Annual Growth Stock Conference
-
Riverside Partners Achieves Partial Exit on its Investment in Revecore
-
New Nonprofit Ownership Works Launches Movement to Help Create at Least $20 Billion in Wealth for Working Families Through Employee Ownership Programs
-
GrowthCurve Capital Completes Acquisition of Revecore to Support Continued Growth and Innovation
-
Arista Networks to Announce Q1 2022 Financial Results on Monday, May 2nd, 2022
-
CAIS Announces Members of CAIS Advisory Council
-
William Blair Reiterates Outperform Rating on Biohaven Pharmaceutical (BHVN), Sees Nurtec ODT as Leader in Migraine Therapies
-
First Women's Bank announces new partners Microsoft and United Airlines to support the women's economy
-
Thomas H. Lee Partners Acquires Intelligent Medical Objects
-
Grid Dynamics to Participate in Virtual Non-Deal Roadshows with JP Morgan and William Blair
-
William Blair Reiterates Outperform Rating on Kinnate Biopharma (KNTE), Sees Potential for Significant Upside in Shares
-
PRO Unlimited to Acquire Geometric Results, Inc., a Leading Managed Services Provider
-
William Blair Reiterates Outperform Rating on Eagle Pharmaceuticals (EGRX), Sees Multiple Possibilities for Further Upside
-
Berkshire Partners and Warburg Pincus to partner for an investment in Ensemble Health Partners
-
Berkshire Partners and Warburg Pincus to partner for an investment in Ensemble Health Partners
-
Eagle Pharmaceuticals (EGRX) to Acquire Acacia Pharma Group for EUR 94.7M
-
Eagle Pharmaceuticals Agrees to Terms to Acquire Acacia Pharma Group plc
-
Offer by Eagle Pharmaceuticals, Inc.
-
Form D WILLIAM BLAIR MB INVESTM
-
William Blair Reiterates Outperform Rating on 9 Meter Biopharma (NMTR), Shares Have Assymetric Risk/Reward
-
Form 24F-2NT WILLIAM BLAIR FUNDS For: Dec 31
-
Forge Global, Inc. and Motive Capital Corp Announce Closing of Business Combination to Create the First Publicly Traded Private Securities Marketplace
-
Form 24F-2NT WILLIAM BLAIR FUNDS For: Oct 31
-
Form D WILLIAM BLAIR MB INVESTM
-
Form D WILLIAM BLAIR MB INVESTM
-
William Blair Investment Management Introduces Mid Cap Value Fund
-
Reaction Biology Announces Closing of Growth Investment from Cobepa and Chief Executive Officer Transition
-
Shift (SFT) Acquires Fair’s Dealer Listing Marketplace Technology
-
Shift to Acquire Fair’s Dealer Listing Marketplace Technology, Team to Expand E-commerce Auto Platform; SoftBank Group to Fully Fund Acquisition
-
Shift to Acquire Fair’s Dealer Listing Marketplace Technology, Team to Expand E-commerce Auto Platform; SoftBank Group to Fully Fund Acquisition
-
Form D/A William Blair China A-Sh
-
William Blair Reiterates Brickell Biotech (BBI) at Outperform, Sees "Strong Risk/Reward Profile" at Current Valuations

